The incidence and prevalence of Huntington's disease (HD) based on a systematic review
and meta‐analysis of 20 studies published from 1985 to 2010 was estimated at 0.38 per …

The ascertained prevalence of Huntington's disease (HD) increased significantly following
the provision of diagnostic testing. A systematic review was conducted to estimate the …

A spermatozoon is a male germ cell capable of fertilizing an oocyte and carries genetic
information for determining the sex of the offspring. It comprises autosomes and an X (X …

In this chapter, we review the evolution of our understanding of the genetic aspects of HD,
and the applications of our understanding in the management of Huntington's disease …

Huntington's disease (HD) is a progressive neurodegenerative condition. At-risk individuals
have accessed predictive testing via direct mutation testing since 1993. The UK Huntington's …

Huntington disease (HD) is an autosomal-dominant neurologic disorder caused by an
expanded CAG trinucleotide repeat mutation in patients with characteristic motor signs and …

Introduction: Understanding the epidemiology of Huntington's disease (HD) is key to
assessing disease burden and the healthcare resources required to meet patients' needs …

Objectives The prevalence of Huntington's disease (HD) recorded in the UK primary care
records has increased twofold between 1990 and 2010. This investigation was undertaken …

Object To estimate the prevalence of Huntington's disease (HD) in Finland. Methods
Persons diagnosed with HD from 1987 to 2010 were identified in the national registers and …

Bacillus Calmette-Guérin (BCG) is the first developed vaccine to prevent tuberculosis (TB)
and is the world's most widely used vaccine. It has a reconcilable defense in opposition to …